MB "Biotechnologiniai projektai" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 101,015 |
| - |
| -39,486 |
| -39,486 |
| - |
| 11.48 |
| -39.09 |
| -5,707 |
| 18,805 |
| 9,801 |
| 3,297 |
| 2024 |
|---|
| 151,441 |
| - |
| -9,449 |
| -9,449 |
| - |
| 25.44 |
| -6.24 |
| -15,156 |
| 25,123 |
| 6,931 |
| 3,036 |
| 2025 |
|---|
| 205,813 |
| - |
| -1,788 |
| -1,788 |
| - |
| 11.58 |
| -0.87 |
| -16,944 |
| 24,728 |
| 4,612 |
| 3,172 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 205,813 |
| - |
| -1,788 |
| -1,788 |
| - |
| 11.58 |
| -0.87 |
| -16,944 |
| 24,728 |
| 4,612 |
| 3,172 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
205,813 €36 % *
Sales per employee (€)
-Profit before tax (€)
-1,788 €81 % *
Net Profit (€)
-1,788 €81 % *
Profit per employee (€)
-Total profitability (%)
11.58 %-54.48 % *
Net profitability (%)
-0.87 %86.06 % *
Equity (€)
-16,944 €-12 % *
Amounts Payable And Liabilities (€)
24,728 €-2 % *
Non-current Assets (€)
4,612 €-33 % *
CurrentAssets (€)
3,172 €4 % *
